KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Dahl N, August P, Besse W, Chebib F, Chonchol M, Cowley B, Goral S, Guay-Woodford L, Gulati A, Hogan M, Lakhia R, Miskulin D, Nowak K, Rahbari-Oskoui F, Park M, Seliger S, Yu A, Watnick T. KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). American Journal Of Kidney Diseases 2026, 87: 447-507. PMID: 41864657, DOI: 10.1053/j.ajkd.2025.11.006.Peer-Reviewed Original Research
ConceptsKidney Disease Outcomes Quality InitiativeAutosomal dominant polycystic kidney diseaseClinical practice guidelinesTreatment of autosomal dominant polycystic kidney diseaseDominant polycystic kidney diseasePolycystic kidney diseasePractice guidelinesKDIGO guidelinesKidney diseaseContext of clinical practiceWorking GroupChronic kidney disease managementHigh-quality evidenceProgression of diseaseKidney disease managementEvidence baseExtrarenal manifestationsKidney manifestationsKDIGODisease managementQuality InitiativeGuideline statementsClinical practiceGuidelinesDisease